You have probably seen the adds. With Keytruda there is a chance to live longer. But how much longer?
120 more words
Among patients whose PD-L1 levels were from 1% to 19%, those who got Keytruda lived for a median of 16.7 months after diagnoses while those who got chemotherapy lived a median of 12.8 months.